Zomedica (ZOM) News Today → Biotech's Best Kept Secret: Potential 46,751% Gain (From Behind the Markets) (Ad) Free ZOM Stock Alerts $0.17 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 29, 2024 | finanznachrichten.deZomedica Corp.: Zomedica Enhances TRUFORMA Platform With Launch of Advanced Canine Cortisol AssayMay 29, 2024 | finance.yahoo.comZomedica Enhances TRUFORMA(R) Platform With Launch of Advanced Canine Cortisol AssayMay 23, 2024 | finance.yahoo.comZomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) TherapyMay 21, 2024 | finance.yahoo.comZomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024May 18, 2024 | insidertrades.comInsider Buying: Zomedica Corp. (NYSEAMERICAN:ZOM) Director Purchases 100,000 Shares of StockMay 15, 2024 | insidertrades.comZomedica Corp. (NYSEAMERICAN:ZOM) COO Anthony K. Blair Buys 150,000 SharesMay 14, 2024 | marketbeat.comInsider Buying: Zomedica Corp. (NYSEAMERICAN:ZOM) COO Buys 150,000 Shares of StockZomedica Corp. (NYSEAMERICAN:ZOM - Get Free Report) COO Anthony K. Blair purchased 150,000 shares of the stock in a transaction dated Monday, May 13th. The shares were bought at an average price of $0.14 per share, with a total value of $21,000.00. Following the completion of the acquisition, the chief operating officer now directly owns 150,000 shares of the company's stock, valued at approximately $21,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.May 14, 2024 | msn.comZomedica And 3 Other Stocks Under $3 Insiders Are BuyingMay 14, 2024 | insidertrades.comLarry C. Heaton II Purchases 100,000 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) StockMay 10, 2024 | finance.yahoo.comZomedica Corp (ZOM) Q1 2024 Earnings: Revenue Climbs Amidst Rising Costs, Aligns with Analyst ...May 9, 2024 | markets.businessinsider.comZomedica earnings: here's what Wall Street expectsMay 6, 2024 | finanznachrichten.deZomedica Corp.: Zomedica Expands International Reach with CE Certification for VetGuardian SystemApril 2, 2024 | msn.comZomedica Corp. (AMEX:ZOM) Q4 2023 Earnings Call TranscriptApril 2, 2024 | finance.yahoo.comQ4 2023 Zomedica Corp Earnings CallApril 1, 2024 | investorplace.comZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023April 1, 2024 | msn.comZomedica reports Q4 resultsApril 1, 2024 | investorplace.comThe Next Millionaire-Makers: 3 Penny Stocks With Massive Upside PotentialMarch 15, 2024 | investing.comZomedica Pharmaceuticals Corp (ZOM)March 12, 2024 | finanznachrichten.deSidoti & Company, LLC: Sidoti Events, LLC's Virtual March Small-Cap ConferenceMarch 12, 2024 | finanznachrichten.deZomedica Corp.: Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary ConferencesMarch 1, 2024 | uk.finance.yahoo.comZomedica Pharmaceuticals Corp. (ZOM)February 8, 2024 | finanznachrichten.deZomedica Corp.: Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health ConferencesFebruary 8, 2024 | finance.yahoo.comZomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health ConferencesFebruary 6, 2024 | finanznachrichten.deZomedica Corp.: Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share ConsolidationFebruary 6, 2024 | finance.yahoo.comLeading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)February 6, 2024 | finance.yahoo.comZomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ETFebruary 6, 2024 | marketbeat.comZomedica (NYSEAMERICAN:ZOM) Shares Down 5% Zomedica (NYSEAMERICAN:ZOM) Trading Down 5%February 4, 2024 | finance.yahoo.comZomedica Corp. (ZOM) Interactive Stock Chart - Yahoo FinanceJanuary 31, 2024 | finance.yahoo.comOpen Letter to Zomedica Shareholders from your Chief Executive OfficerJanuary 30, 2024 | morningstar.comZomedica Corp Ordinary SharesJanuary 30, 2024 | finance.yahoo.comZomedica to Participate in the Lytham Partners 2024 Investor Select ConferenceJanuary 17, 2024 | finanznachrichten.deZomedica Corp.: Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share ConsolidationJanuary 17, 2024 | msn.comZomedica says Q4 revenue is expected to be over $7MJanuary 17, 2024 | finance.yahoo.comZomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")January 16, 2024 | msn.com3 Breakout Penny Stocks Primed for Massive GainsJanuary 10, 2024 | finance.yahoo.comZomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of Shareholders on February 28, 2024January 4, 2024 | finance.yahoo.comZomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel “X-Trode” HandpieceDecember 22, 2023 | ca.finance.yahoo.comZomedica Corp. (ZOM) Stock Historical Prices & Data - Yahoo FinanceDecember 18, 2023 | finance.yahoo.comZomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal DiseaseDecember 6, 2023 | finance.yahoo.comZomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine PractitionersNovember 20, 2023 | finance.yahoo.comZomedica to Present at the 35th Annual Piper Sandler Healthcare ConferenceNovember 14, 2023 | investing.comZomedica Pharma (ZOM) Earnings Dates & ReportsNovember 14, 2023 | finance.yahoo.comZomedica Corp. (AMEX:ZOM) Q3 2023 Earnings Call TranscriptNovember 13, 2023 | finance.yahoo.comZomedica Corp (ZOM) Posts Record Q3 Revenue with Significant Gross Margin ImprovementNovember 13, 2023 | msn.comZomedica reports Q3 resultsNovember 13, 2023 | finance.yahoo.comZomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo BiotechnologiesNovember 4, 2023 | markets.businessinsider.comZomedica Corp Registered Shs hosts conference call for investorsNovember 2, 2023 | finance.yahoo.comZomedica to Report Third Quarter 2023 Financial Results and Provide Business Update on November 13 at 4:30 p.m. ETOctober 11, 2023 | finanznachrichten.deZomedica Corp.: Zomedica to Participate in the Lytham Partners Fall 2023 Investor ConferenceOctober 11, 2023 | finance.yahoo.comZomedica to Participate in the Lytham Partners Fall 2023 Investor Conference Get Zomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ZOM and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”. You just have to make this simple move before July 30, 2024. ZOM Media Mentions By Week ZOM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZOM News Sentiment▼0.750.76▲Average Medical News Sentiment ZOM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZOM Articles This Week▼21▲ZOM Articles Average Week Get Zomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ZOM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ANAB News AVBP News HROW News DNTH News ABUS News MLYS News SLN News PHAR News ORIC News PHGUF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:ZOM) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zomedica Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
